MAPT and Alzheimer disease: Pathogenic tau protein exerts destructive effects that are associated with cerebral degenerations such as AD, PSP, and TBI, and ocular neurodegenerative disorders such as AMD, glaucoma/ocular hypertension, and probably diabetic retinopathy.